Drugs / MencevaxACWY TM
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01235975 Comparator | Nov 2010 → Jul 2011 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MencevaxACWY TM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01235975 ↗ |
| Modality | Vaccine | “meningococcal polysaccharide vaccine MencevaxACWYTM” NCT01235975 ↗ |
| Route | Subcutaneous | “Subcutaneous injection” NCT01235975 ↗ |